Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Clear all

2,320 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200125
200245
200359
200467
200579
2006107
200782
200895
200988
201052
201160
201265
201367
201456
201572
201673
201787
201896
201995
2020109
2021126
2022118
202399
2024122
2025131
2026142

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed942
Unknown status389
Recruiting294
Terminated293
Active, not recruiting146
Not yet recruiting143
Withdrawn103
Suspended7
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company70
National Cancer Institute (NCI)70
Sun Yat-sen University56
M.D. Anderson Cancer Center42
Pfizer32
AstraZeneca29
Memorial Sloan Kettering Cancer Center29
Alliance for Clinical Trials in Oncology28
Fudan University27
Tianjin Medical University Cancer Institute and Hospital27

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2,320
Lung Neoplasms593
Adenocarcinoma of Lung110
Neoplasms81
Neoplasm Metastasis73
Brain Neoplasms72
Breast Neoplasms60
Small Cell Lung Carcinoma58
Adenocarcinoma, Bronchiolo-Alveolar53
Melanoma51

Trials

Showing 76 to 100 of 2,320. Each trial links to its page on Pharma Observatory.

2,220 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.